Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
A61F 2/958 - Instruments spécialement adaptés pour insérer ou retirer les stents ou les endoprothèses déployables couvertes ballons gonflables pour insérer les stents ou les endoprothèses déployables couvertes
A61B 5/06 - Dispositifs autres que ceux à radiation, pour détecter ou localiser les corps étrangers
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
A61F 5/00 - Procédés ou dispositifs d'orthopédie pour le traitement non chirurgical d'os ou articulationsDispositifs pour donner des soins
A61F 2/958 - Instruments spécialement adaptés pour insérer ou retirer les stents ou les endoprothèses déployables couvertes ballons gonflables pour insérer les stents ou les endoprothèses déployables couvertes
Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
6.
SYSTEMS AND METHODS FOR LOCATING AND/OR CHARACTERIZING INTRAGASTRIC DEVICES
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
A61B 5/06 - Dispositifs autres que ceux à radiation, pour détecter ou localiser les corps étrangers
A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. More particularly, apparatuses and methods for enabling volume-occupying intragastric devices to pass through the digestive system are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices, systems, and uses therefor are provided as well as and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. According to one embodiment, a dispenser for filling an intragastric balloon is described, the dispenser comprising: a gas canister housing with a locking mechanism; a touch screen housing; a tunnel housing comprising a tunnel extending longitudinally therefrom to a disconnect valve; and a plurality of valves for controlling flow of an inflation gas through and out of the dispenser. The dispenser may be configured such that an inflation fluid canister is engaged in the gas canister housing and locked in place by a locking mechanism.
A61B 17/12 - Instruments, dispositifs ou procédés chirurgicaux pour ligaturer ou comprimer par un autre moyen les parties tubulaires du corps, p. ex. les vaisseaux sanguins ou le cordon ombilical
A61M 29/00 - Dilatateurs avec ou sans moyens pour introduire des agents, p. ex. des remèdes
A61F 2/04 - Éléments ou organes creux ou tubulaires, p. ex. vessies, trachées, bronches ou voies biliaires
12.
SYSTEMS AND METHODS FOR DETERMINING FAILURE OF INTRAGASTRIC DEVICES
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, apparatuses and methods for preventing volume-occupying intragastric devices from passage through the digestion system, are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
A61M 29/00 - Dilatateurs avec ou sans moyens pour introduire des agents, p. ex. des remèdes
A61F 2/00 - Filtres implantables dans les vaisseaux sanguinsProthèses, c.-à-d. éléments de substitution ou de remplacement pour des parties du corpsAppareils pour les assujettir au corpsDispositifs maintenant le passage ou évitant l'affaissement de structures corporelles tubulaires, p. ex. stents
Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
Devices and methods for treating obesity are provided. More particularly,intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
A61M 29/04 - Dilatateurs faits de matériaux dilatables
A61F 2/958 - Instruments spécialement adaptés pour insérer ou retirer les stents ou les endoprothèses déployables couvertes ballons gonflables pour insérer les stents ou les endoprothèses déployables couvertes
A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps
Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo. In a preferred embodiment, a swallowable, intragastric volume-occupying device is provided comprising a compacted balloon (445) having therein a silicone head (441) with radioopacity ring (442), a silicone septum (443), an inoculation spacer (444), an inner container (446), and outer container (447).
An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents. In a preferred embodiment, a swallowable, intragastric volume-occupying device is provided comprising a compacted balloon 445 having therein a silicone head 441 with radioopacity ring 442, a silicone septum 443, an inoculation spacer 444, an inner container 446, and outer container 447.
A self-inflating and self-deflating orally ingestible device that is able to traverse the entirety of the alimentary canal is described. In one embodiment, the device includes a closed balloon having a surface separating an enclosed space internal to the balloon from a space external to the balloon, at least one self-sealing valve integrated with the surface of the balloon to provide access to the enclosed space internal to the balloon from the space external to the balloon, a vent comprised of a dissolvable seal integrated with the surface of the balloon, and a vessel located within the enclosed space internal to the balloon to separate internal contents of the vessel from the enclosed space internal to the balloon.
